Typical client
Italian companies
Pharma, biotech, medical devices, and healthcare service providers: typically family- or founder-controlled, evaluating strategic options.
Sector focus
Life Sciences.
Life Sciences, medical devices, digital health.
The Italian life sciences sector — specialty pharma, medical devices, diagnostics, digital health, biotech — is characterized by strong regulation, high R&D intensity, and consolidation dynamics driven by international players. Montesino supports entrepreneurs on sales to international pharma groups and dedicated healthcare funds, and supports PE funds on platform transactions in the Italian mid-market.
Who it's for
One sector, three lenses.
Pharmaceutical, medical devices, and digital health operators: three perspectives on a sector in full European consolidation activity.
Typical client
Specialized funds
Healthcare-focused PE and biotech venture capital active in the European mid-market for acquisitions, exits, and scale-up transactions.
Typical client
Global strategics
Big pharma, international medical device groups, and digital health operators seeking Italian assets with distinctive positioning.
What we do
Recurring transactions in the sector.
Life sciences is a sector where product quality, pipeline, and regulatory framework define value. Montesino brings technical sensitivity and access to specialized investors.
Type
Sales to strategics
Sell-side advisory for founders and families toward big pharma or medical device groups.
Type
Capital raising
Rounds for scale-up operators, from Series A to growth.
Type
Licensing and partnerships
Structuring of commercial agreements with corporate implications (royalties, milestones, equity).
Type
Cross-border transactions
Coordination of complex deals with international counterparties and multiple regulators.
Sector insight
Sector insights.
REPORT
Sector map and key players
NOTE
Consolidation trends and recent M&A activity
ARTICLE
Current multiples and valuation benchmarks
REPORT
Cross-border outlook and international investors
The team
Lead partner.
Ugo Zampieri
Partner
Senior expert with over 25 years in M&A and debt restructuring across IT, business services, and healthcare, with Italian and cross-border experience. Originator of mandates for several IPOs on the EGM segment (formerly AIM Italia of Borsa Italiana).
Gian Piero Sala
President
Chartered accountant since 1993, court-appointed expert (CTU) at the Tribunal of Milano (Milan). Cross-border M&A negotiations.
Mirco Galeri
Managing Partner
Thirty years of strategic and operational management, combining direct entrepreneurial activity and executive advisory. CFO and Executive Committee member at top-tier companies, with cross-sector experience in metals & mechanics, chemicals, agriculture, and services.
Riccardo Puddu Cortesi
Managing Partner
Business development and SME internationalization. Cross-border coordination with Montesino Associates LLC.